Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
OneMedNet Corp. (ONMDW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/12/2025: ONMDW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -80.71% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/12/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.76 | 52 Weeks Range 0.01 - 0.08 | Updated Date 05/26/2025 |
52 Weeks Range 0.01 - 0.08 | Updated Date 05/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1623.36% |
Management Effectiveness
Return on Assets (TTM) -489.93% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 15312402 |
Shares Outstanding - | Shares Floating 15312402 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
OneMedNet Corp.
Company Overview
History and Background
OneMedNet Corp. was founded in 2009. They provide a secure, regulatory-compliant platform for sharing healthcare data.
Core Business Areas
- Provider Data Sharing: Facilitates secure and compliant data sharing between healthcare providers, enabling better care coordination and research.
- Clinical Trial Data: Offers solutions to streamline the use of real-world data in clinical trials, enhancing efficiency and patient outcomes.
- Research Data: Provides secure access to de-identified data for research purposes, accelerating scientific discovery.
Leadership and Structure
Christopher Hanna is the CEO. The company has a typical hierarchical structure with departments focused on technology, sales, marketing, and operations.
Top Products and Market Share
Key Offerings
- iRWD Platform: A comprehensive platform for compliant data sharing. Limited market share data available. Competitors include Truveta and Health Catalyst.
- OneMedNet OC: Enables secure access to de-identified data for use in clinical trials, helping speed up clinical development. Competitors include TriNetX and Datavant.
Market Dynamics
Industry Overview
The healthcare data sharing market is growing due to increased demand for interoperability, real-world data, and personalized medicine.
Positioning
OneMedNet is positioned as a solution for compliant data sharing for use in clinical trials and research. Their competitive advantage is their iRWD platform.
Total Addressable Market (TAM)
Estimated TAM for healthcare data sharing exceeds $25 billion. OneMedNet's position is focused on compliant data and access to de-identified data.
Upturn SWOT Analysis
Strengths
- Strong iRWD Platform
- Regulatory compliance expertise
- Established relationships with healthcare providers
- Experienced leadership team
Weaknesses
- Limited brand recognition
- Smaller market share compared to larger competitors
- Dependence on partnerships
- Profitability is still in the development stages
Opportunities
- Growing demand for real-world data
- Expansion into new markets (e.g., international)
- Partnerships with pharmaceutical companies
- Increased adoption of telehealth and remote patient monitoring
Threats
- Data security breaches
- Changing regulatory landscape
- Competition from larger players
- Economic downturn impacting healthcare spending
Competitors and Market Share
Key Competitors
- TRHC
- IQV
- ALGN
- GH
Competitive Landscape
OneMedNet's advantages are its regulatory expertise and iRWD Platform. Its disadvantage is its smaller size and brand recognition compared to competitors.
Major Acquisitions
N/A
- Year: 0
- Acquisition Price (USD millions): 0
- Strategic Rationale: N/A
Growth Trajectory and Initiatives
Historical Growth: Growth driven by increased demand for healthcare data sharing. Exact figures not publicly available.
Future Projections: Projected growth based on industry trends. No specific projections available.
Recent Initiatives: Focus on expanding its iRWD Platform, and expanding partnerships with new providers.
Summary
OneMedNet is a small growing company with a solid product that provides compliant data sharing and access to de-identified data for use in clinical trials. OneMedNet's small size may present a competitive challenge when stacked against the advantages of larger competitors. Focusing on strategic initiatives and expansion plans will ensure steady revenue growth in the future. Given the increasing demand for data sharing in healthcare, OneMedNet is positioned for growth but needs to build stronger brand awareness.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Crunchbase
- OneMedNet Corp Website
- Third-Party Industry Reports
Disclaimers:
Data is based on available public information and may not be completely accurate. This analysis is for informational purposes only and not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OneMedNet Corp.
Exchange NASDAQ | Headquaters Eden Prairie, MN, United States | ||
IPO Launch date 2021-06-24 | CEO, President & Director Mr. Aaron Green | ||
Sector Healthcare | Industry Health Information Services | Full time employees 22 | Website https://www.onemednet.com |
Full time employees 22 | Website https://www.onemednet.com | ||
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets; and BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.